DFAC vs XLV
Dimensional US Core Equity 2 ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.18% for DFAC.
Side-by-side metrics
| Metric | DFAC | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.18% | 0.08% |
Dividend yield Trailing 12-month yield. | — | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $87.72B | $49.10B |
YTD return | 13.31% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.94 | 0.41 |
P/E ratio | 21.44 | 30.63 |
Last price | $45.22 | $187.94 |
Inception | — | — |
Issuer | Dimensional | State Street |
DFAC top holdings
| NVDA | NVIDIA Corp | 5.99% |
| AAPL | Apple Inc | 5.76% |
| MSFT | Microsoft Corp | 4.57% |
| META | Meta Platforms Inc Class A | 2.22% |
| AMZN | Amazon.com Inc | 2.03% |
| GOOGL | Alphabet Inc Class A | 1.74% |
| GOOG | Alphabet Inc Class C | 1.24% |
| JPM | JPMorgan Chase & Co | 1.22% |
| MU | Micron Technology Inc | 1.13% |
| AVGO | Broadcom Inc | 1.09% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About DFAC
DFAC (Dimensional US Core Equity 2 ETF) is Broad US equity market with small and value tilts. Managed by Dimensional, the fund carries $87.7B in assets under management, an expense ratio of 0.18%. Its largest holding is NVIDIA Corp (NVDA), which represents 6.0% of the portfolio. Real Estate is the fund's largest sector exposure at 0.2%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.